Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Doctor launches the first online clinic dedicated to using common drugs for a different purpose: to slow aging

Doctor launches the first online clinic dedicated to using common drugs for a different purpose: to slow aging

Sajad Zalzala wants to enable off-label uses of common drugs, like Metformin, to slow aging.

He’s starting an online clinic to help people get prescriptions for drugs like Metformin, which is increasingly popular in the tech community.

Metformin is routinely prescribed to people with diabetes, but some are using it in the hopes of slowing the aging process.

One of the many wild medical pursuits in Silicon Valley is the effort to slow down the aging process. Sajad Zalzala is trying to make it a reality.

Zalzala, a 38-year-old family medicine doctor based in the Detroit area, has just opened an online clinic called Qalytude, dedicated to anti-aging. As a physician licensed to practice in all 50 states, Zalzala can treat patients anywhere in the country by phone or online, in addition to those who visit his physical clinic.

Initially, Zalzala will be targeting the small but growing segment of Americans who take medicines like Metformin, a type 2 diabetes drug, but for the unintended purpose of staving off aging. Researchers are now finding evidence of reduced cancer risk in the drug, and studies in mice have shown potential for an improved life span, but scientists warn that it might not produce the same result in humans.

“There’s this movement around Metformin that I could see having a snowball effect,” Zalzala told CNBC.

He’s jumping into a market for anti-aging services, products and technologies that’s expected to reach $271 billion by 2024, according to Market Research Engine. Venture capital funds are dabbling in the space as are billionaires like Jeff Bezos and biohackers, who experiment with drugs and supplements for health and longevity purposes.


Making it easier

Zalzala said that only a few clinicians are trained in this field, and they’re highly costly to see and often backed up with patients. Many primary care physicians won’t prescribe Metformin to people who don’t have diabetes until they better understand whether it’s safe.

Zalzala’s goal is to make it easier for people interested in drugs like Metformin to talk to a physician. He plans to hire a team of doctors to conduct research into Metformin and other drugs — both their safety and efficacy — and prescribe them virtually to patients while monitoring them for side effects.

Having previously worked for a handful of virtual medical companies, including Hims and Pill Club, Zalzala is familiar with the model. Hims and Roman are among companies that have sprung up in recent years to help people get medications for erectile dysfunction and hair loss, the types of things that patients are often embarrassed to discuss with a family doctor. Other companies are prescribing medication virtually for birth control, sexual health and prevention, anxiety and attention deficit hyperactivity disorder.

Some of these companies require that patients talk to their doctor via video, while others request only that the user fill out a survey. The laws that govern how engaged a physician must be in the process vary by state.

For an area like anti-aging, a medical expert needs to be highly involved in the process.

These drugs “always must be prescribed by a doctor,” said Lisa Suennen, managing director of digital and technology at the law firm Manatt, Phelps and Phillips. “Any drug can be dangerous if it is mixed with something contraindicated,” and it’s especially important to be cautious when they’re being used “for claims that aren’t fully vetted.”

The side effects for Metformin include diarrhea, low blood sugar and abdominal pain, as well as a condition called lactic acidosis that involves excessive acid building up in the body. It also still isn’t well understood whether the drug will provide benefits to healthy people, particularly those who exercise regularly.

Another medicine Zalzala is exploring is rapamycin, which has an immunosuppressant function and is useful in helping patients avoid rejected transplanted kidneys. He’s also looking into so-called NAD booster patches. Both interventions are starting to get tested in the Silicon Valley tech community for their anti-aging effects, even though there are health risks.

Zalzala said he intends to be especially conservative with these untested therapies, but he didn’t rule out the possibility of prescribing them. He said that he will recommend lifestyle and dietary changes and not just pills.

“Most of us don’t have the perfect lifestyle,” he said. “So I’m hoping to add an extra layer of protection.”

AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
Russia’s A7 Builds a State-Linked Payments Network Beyond Western Sanctions
AI’s Next Bottleneck Is Power, Not Just Nvidia Chips
Meta Raises AI Spending Target to as Much as $145bn Despite Pressure Over Returns
Danube Drought Exposes Nazi Wrecks and Pushes Central Europe’s Power System to the Brink
Joe Biden’s Cancer Has Spread Beyond His Bones, Hunter Biden Says
Why 2027 Could Be a Strong Year for Stocks—and Why the Forecast Is Fragile
Why Markets May Look Quiet in August After Big Tech Earnings
UK Drought Cuts Harvests and Raises Food-Security Fears
UFO: Pentagon Releases Video of Unidentified Object Tracked Over Middle East
Ukraine Tells Senate Republicans Its Drone War Offers a Blueprint for America
Weight-Loss Drug Boom Tests the Limits of Prescription Advertising Rules
Senate Scrutinises AI-Driven Personalised Pricing
Spain Seeks Mainland Transfers for 1,100 Children Stranded in Ceuta
Spain and Morocco Trade Blame After 72,000 Migrants Enter Ceuta
AI Is Remaking the US Economy, From GDP Growth to iPhone Prices
Europe’s Heat and Drought Are Now Disrupting Power, Shipping and Tourism
Europe’s Drying Rivers Trigger Power Cuts, Factory Shutdowns and Wildfire Emergencies
Record-Low Danube Forces Nuclear Cuts and Emergency Power Curbs
Danube Drought Forces Hungary’s Paks Nuclear Plant Into Full Shutdown
Ceuta Death Toll Rises as Spain and Europe Clash Over Border Response
Valued at $109 Million: F-35B Fighter Jet Crashes in Southern California
Record-Low Danube Exposes Probable Mammoth Remains in Bulgaria
US Says It Has Carried Out Heavy Strikes on Iran After Attempted Attacks on Its Forces
The AI User Nightmare: Private Claude Conversations Leaked to the Internet
Over 24 Hours in the Air: Qantas Airbus Completes Record-Breaking Test Flight
Massive Wildfires Ravage Southern Europe: Fatalities in Greece and Evacuations Across France, Spain, and Turkey
Nvidia Reportedly Takes Vast Texas Data-Centre Lease to Underwrite AI Expansion
FIFA’s Private-Investment Plan for World Cup Rights Draws European Revolt
Apple Briefly Crosses Five Trillion Dollar Valuation as Investors Retreat From AI Bets
Fresh Heatwave Threatens to Rekindle France’s Historic Wildfire Crisis
Following OpenAI's Cyberattack: 'Most Companies Still Do Not Understand What Is Coming'
OpenAI Sued After ChatGPT Allegedly Discouraged Emergency Care Before Near-Fatal Embolism
Miliband Sets Climate and International Law at Centre of UK Diplomacy
Czech Central Bank Governor Rejects Early Euro Entry and Rate-Cut Pressure
Trump Readies New Tariffs as Temporary Global Levy Nears Expiry
Vivienne Westwood Casts Cicciolina, 74, in Its New Autumn Campaign
Dejavu: Germany’s Military Expansion Reshapes Europe’s Strategic Balance With France
Morgan Stanley Builds a Wall Street Lead in AI Infrastructure Finance
High Prices Push Coffee Drinkers Toward Whole Beans and Home Brewing
Trump Draws Boos and Podium Scrutiny at Spain’s World Cup Triumph
Brilliant move: Péter Magyar Moves to Nominate Chess Grandmaster Judit Polgár as Hungary’s President
Spain Defeats Argentina in Extra Time to Win Second World Cup
Current AI Seeks to Build an Open Global AI Infrastructure Outside Big Tech Control
Germany’s Economic Malaise Reopens the Sunday Shopping Debate
Proposed U.S.-Saudi Nuclear Pact Could Permit Limited Uranium Enrichment Under International Safeguards
Netherlands Declares Water Shortage Emergency After Drought Pushes Rivers to Historic Lows
Why Kentucky Fried Chicken Became KFC—and Why the False Explanations Persist
Ukrainian Drones Strike Wildberries Warehouses Deep Inside Russia
Reported CIA Mission Helped Clear the UAE’s Path to Advanced US AI Chips
Artificial Intelligence Capital Fuels Markets While Governments and Regulators Face Mounting Strategic Tests
×